Novel EBP gene mutations in Conradi-Hünermann-Happle syndrome

Br J Dermatol. 2007 Dec;157(6):1225-9. doi: 10.1111/j.1365-2133.2007.08254.x. Epub 2007 Oct 18.

Abstract

Background: Conradi-Hünermann-Happle syndrome [X-linked dominant chondrodysplasia punctata type 2 (CDPX2); MIM no. 302960] is an X-linked dominant disorder of cholesterol metabolism that causes a wide spectrum of skeletal abnormalities and linear ichthyosiform skin lesions. Mosaicism is probably responsible for the variability of the phenotype.

Objectives: To describe new mutations in patients with variable manifestations of the disease.

Methods: We studied three patients with CDPX2. We performed mutation analysis of the EBP (formerly known as CDPX2) gene and gas chromatography-mass spectroscopy on serum of two patients.

Results: We found two novel (3G-->T and 419-422delTTCT) and one known mutation in the EBP gene. We demonstrated the presence of increased levels of dehydrocholesterol and 8(9)-cholestenol in the two patients with new mutations, confirming the diagnosis of CDPX2 and strongly suggesting that the mutations are indeed pathogenic. One patient had a very mild phenotype, presenting with linear alopecia and a mild symmetrical epiphyseal dysplasia. X-inactivation studies in peripheral blood of all patients showed skewing in only the most severely affected patient.

Conclusions: The strong phenotypic variability in our patients suggests that there is no clear genotype-phenotype correlation.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Chondrodysplasia Punctata / diagnosis
  • Chondrodysplasia Punctata / genetics*
  • DNA Mutational Analysis
  • Female
  • Gas Chromatography-Mass Spectrometry
  • Humans
  • Infant
  • Mosaicism
  • Steroid Isomerases / genetics*

Substances

  • Steroid Isomerases
  • EBP protein, human